Direkt zum Inhalt
Merck

T8703

Sigma-Aldrich

T0070907

≥98% (HPLC)

Synonym(e):

2-Chloro-5-nitro-N-4-pyridinyl-benzamide, Benzamide, 2-chloro-5-nitro-N-4-pyridinyl-

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

5 MG
CHF 157.00
25 MG
CHF 629.00

CHF 157.00


Voraussichtliches Versanddatum31. Mai 2025


Bulk-Bestellung anfordern

Größe auswählen

Ansicht ändern
5 MG
CHF 157.00
25 MG
CHF 629.00

About This Item

Empirische Formel (Hill-System):
C12H8ClN3O3
CAS-Nummer:
Molekulargewicht:
277.66
MDL-Nummer:
UNSPSC-Code:
12352203
PubChem Substanz-ID:
NACRES:
NA.77

CHF 157.00


Voraussichtliches Versanddatum31. Mai 2025


Bulk-Bestellung anfordern

Qualitätsniveau

Assay

≥98% (HPLC)

Form

powder

Farbe

white

Löslichkeit

DMSO: >10 mg/mL
H2O: insoluble

Lagertemp.

2-8°C

SMILES String

[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccncc2

InChI

1S/C12H8ClN3O3/c13-11-2-1-9(16(18)19)7-10(11)12(17)15-8-3-5-14-6-4-8/h1-7H,(H,14,15,17)

InChIKey

FRPJSHKMZHWJBE-UHFFFAOYSA-N

Allgemeine Beschreibung

T0070907 has antimicrotubule,[1] antitumor and radiosensitizing properties. It decreases tubulin protein levels, which is associated with cell cycle arrest, apoptosis and also reduces metastasis of colorectal carcinoma cells.[2] T0070907 is used as a therapeutic target in breast cancer.[3] It stimulates proteasome-dependent degradation of tubulin.[4]

Anwendung

T0070907 has been used to reduce peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in lipopolysaccharide (LPS)-induced leukemia RAW264.7 cell line.[5] It also has been used to evaluate the involvement of wogonin in alleviating EtOH (ethanol)-induced inflammation in RAW264.7 cell line.[6]
T0070907 or Benzamide has been used as a ADP-ribosyltransferase (ADPRT) inhibitor in rat hippocampal slices[7]. It has also been used for urine analysis in patients diagnosed with acute uncomplicated urinary tract infection[8].

Biochem./physiol. Wirkung

T0070907 is a PPAR-γ antagonist.
T0070907 is very similar in structure and activity to the PPAR-γ antagonist GW9662. T0070907 is more potent and has higher selectivity for PPAR-γ over all other subtypes (about 800-fold) whereas GW9662 has been reported to have some PPAR-α agonist activity.

Leistungsmerkmale und Vorteile

This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Angaben zur Herstellung

T0070907 is soluble in DMSO at a concentration that is greater than 10 mg/ml.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 2

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Gloves


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Hyperin attenuates inflammation by activating PPAR-gamma in mice with acute liver injury (ALI) and LPS-induced RAW264. 7 cells
Huang C, et al.
International Immunopharmacology, 29(2), 440-447 (2015)
T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51
An Z, et al.
Toxicology in vitro, 37, 1-8 (2016)
The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and-independent mechanisms
Zaytseva YY, et al.
Anticancer Research, 31(3), 813-823 (2011)
Alexandros K Pavlou et al.
Biosensors & bioelectronics, 17(10), 893-899 (2002-09-24)
The use of volatile production patterns produced by bacterial contaminants in urine samples were examined using electronic nose technology. In two experiments 25 and 45 samples from patients were analysed for specific bacterial contaminants using agar culture techniques and the
Wogonin attenuates inflammation by activating PPAR-gamma in alcoholic liver disease
Li HD, et al.
International Immunopharmacology, 50, 95-106 (2017)

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.